Adib Miraki Feriz

Adib Miraki Feriz β€” Gene Banner
   

πŸ‘‹ About Me

I’m a Bioinformatician at the Lotfollahi Lab, Wellcome Sanger Institute, working at the intersection of machine learning, single-cell genomics, and spatial transcriptomics.

My research focuses on decoding the language of cells β€” predicting how they behave, interact, and evolve across different biological contexts. I develop and apply AI-driven frameworks to uncover cellular heterogeneity and perturbation responses in complex tissues.

β€œGiving cells a digital voice and letting data science do the talking.”

🧬 Research Interests: Single-cell & spatial transcriptomics · Perturbation modeling · Tumor immunology · Deep learning for genomics
⚽🚴 Outside the lab: Football · Cycling · Endless curiosity


πŸŽ“ Education

Degree Institution Period Grade
BSc Medical Laboratory Sciences Birjand University of Medical Sciences 2019 – 2023 A (Top of Class)

πŸ’Ό Research Experience

πŸ›  Wellcome Sanger Institute, Cambridge, UK
    On-site Bioinformatician Β· Lotfollahi Lab                    Aug 2025 – Present

🀝  Wellcome Sanger Institute, Cambridge, UK
    Research Collaborator (Remote Contract) Β· Lotfollahi Lab     Feb 2023 – Aug 2025

πŸ”¬  Sharif University of Technology, Tehran, Iran
    Research Intern                                               Oct 2022 – Jan 2023

🧫  Cellular & Molecular Research Center, BUMS
    Research Assistant                                            Apr 2021 – Sep 2022

πŸ“œ Publications

2026

Ly K.C.H.*, Miraki Feriz A.*, Isobe T., Vahidi A., Vaghari D., Rostron A., Quiroga LondoΓ±o M., Mende N., Vijayabaskar M.S., Moullet M., Rose Foster A., et al.
Predicting how perturbations reshape cellular trajectories with PerturbGen.
bioRxiv 2026 β€” ⭐ Co-first author Β· Under review at Nature Β· πŸ“„ Paper Link


Gharaie Amirabadi D., Miraki Feriz A., Safarpour H.
Multimodal foundation models in colorectal cancer: from prediction to trustworthy clinical insight.
Briefings in Bioinformatics, Volume 27, Issue 2, March 2026 Β· πŸ“„ Paper Link


Akbarnejad A.*, Steele L.*, He Z.*, Jafree D.J.*, Birk S.*, Leonardi C.*, Sallese M.R.*, Boxall A., Miraki Feriz A., Raghubar A.M., Vaghari D., Gopee N.H., Rademaker K., Rumney B., Tudor C., Patel M., Prete M., Makarchuk S., Lee C.Y.C., Maaskola J., Li T., Stanley H., Foster A.R., Roberts K., Trinh A.L., Villa C.E., Testa G., Mahil S., Mehrjou A., Smith C., Vakili S., Jones J.O., Stewart G.D., Clatworthy M.R., Bayraktar O.A., Mitchell T., Haniffa M., Lotfollahi M.
Mapping and reprogramming human tissue microenvironments with MintFlow.
bioRxiv 2025 β€” ⭐ Under review at Nature Β· πŸ“„ Paper Link


2025

Birk S., Bonafonte-PardΓ s I., Miraki Feriz A., Boxall A., Agirre E., Memi F., … & Lotfollahi M.
Quantitative characterization of cell niches in spatially resolved omics data.
Nature Genetics, 57:897–909, 2025 Β· πŸ“„ Paper Link


Geravandi S., Liu H., Pahwa H., Madduri M.K., Atawneh F., Miraki Feriz A., …, Gotti D.
The Hippo terminal effector YAP boosts enterovirus replication in type 1 diabetes.
Nature Communications, 16(1):8882, 2025 Β· πŸ“„ Paper Link


2024

Miraki Feriz A., Khosrojerdi A., Erfanian N., Azarkar S., Sajjadi S.M., …, Racanelli V.
Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from scRNA-seq with a focus on CTLA4 and TIGIT.
Immunobiology, 229(4):152822, 2024 Β· πŸ“„ Paper Link


Shadbad M.A., Miraki Feriz A., Baradaran B., Safarpour H.
Tumor-infiltrating CD8+ sub-populations in primary and recurrent glioblastoma: An in-silico study.
Heliyon, 10(5):e27329, 2024 Β· πŸ“„ Paper Link


Safarpour H., Ranjbaran J., Erfanian N., Nomiri S., Derakhshani A., Gerarduzzi C., Miraki Feriz A., …, Silvestris N.
Holistic exploration of CHGA and hsa-miR-137 in colorectal cancer via multi-omic data integration.
Heliyon, 2024 Β· πŸ“„ Paper Link


2023

Miraki Feriz A., Khosrojerdi A., Lotfollahi M., Shamsaki N., …, Saghafi S., Leone P.
Single-cell RNA sequencing uncovers heterogeneous transcriptional signatures in tumor-infiltrated dendritic cells in prostate cancer.
Heliyon, 9(5):e15694, 2023 Β· πŸ“„ Paper Link


Miraki Feriz A., Bahraini F., Khosrojerdi A., Azarkar S., …, Safarpour H.
Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy.
PLOS ONE, 18(12):e0295863, 2023 Β· πŸ“„ Paper Link


Erfanian N., Nasseri S., Miraki Feriz A., Safarpour H., Namaie M.H.
Characterization of Wnt signaling pathway under treatment of Lactobacillus acidophilus postbiotic in colorectal cancer using an integrated in silico and in vitro analysis.
Scientific Reports, 13(1):22988, 2023 Β· πŸ“„ Paper Link


Erfanian N., Heydari A.A., Miraki Feriz A., IaΓ±ez P., Derakhshani A., …, Sahebkar A.
Deep learning applications in single-cell genomics and transcriptomics data analysis.
Biomedicine & Pharmacotherapy, 165:115077, 2023 Β· πŸ“„ Paper Link


Sanadgol N., Miraki Feriz A., Lisboa S.F., Joca S.R.
Putative role of glial cells in treatment resistance depression: An updated critical literature review and evaluation of single-nuclei transcriptomics data.
Life Sciences, 331:122025, 2023 Β· πŸ“„ Paper Link


2022

Derakhshani A., Asadzadeh Z., Baradaran B., Safarpour H., Rahmani S., Leone P., Shadbad M.A., …, Miraki Feriz A., …, Ahmadi H.
The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study.
Biomedicine & Pharmacotherapy, 148:112725, 2022 Β· πŸ“„ Paper Link


πŸ† Honors & Awards

Year Award
2025 πŸ₯ˆ Rank 2nd β€” AI Hackathon, Birjand University of Medical Sciences
2023 πŸ… Best Researcher of Iran among Undergraduate Students (National)
2023 πŸ… Best Researcher β€” Birjand University of Medical Sciences
2022 πŸ… Best Researcher β€” Birjand University of Medical Sciences
2022 🎀 Best Oral Presenter β€” 9th International Congress of Medical Students

πŸ“ Academic Service


🀝 References

Name Role
Prof. Muzlifah Haniffa Senior Group Leader, Wellcome Sanger Institute & University of Cambridge
Dr. Γ–mer Ali Bayraktar Group Leader, Wellcome Sanger Institute
Dr. Mohammad Lotfollahi Group Leader, Wellcome Sanger Institute (Supervisor)

*Available upon request for academic and research positions.*